POINT BIOPHARMA GLOBAL INC's ticker is PNT and the CUSIP is 730541109. A total of 117 filers reported holding POINT BIOPHARMA GLOBAL INC in Q1 2023. The put-call ratio across all filers is 0.02 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $364,015 | -28.1% | 54,575 | -2.3% | 0.00% | 0.0% |
Q2 2023 | $506,110 | +18.3% | 55,862 | -5.1% | 0.00% | 0.0% |
Q1 2023 | $427,789 | -10.3% | 58,843 | -10.0% | 0.00% | -50.0% |
Q4 2022 | $476,664 | +32.4% | 65,386 | +40.6% | 0.00% | +100.0% |
Q3 2022 | $360,000 | +33.3% | 46,509 | +17.2% | 0.00% | 0.0% |
Q2 2022 | $270,000 | +13.4% | 39,683 | +32.7% | 0.00% | – |
Q1 2022 | $238,000 | – | 29,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
GREAT POINT PARTNERS LLC | 3,383,029 | $24,594,621 | 4.83% |
Velan Capital Investment Management LP | 494,136 | $3,592,369 | 3.06% |
BVF INC/IL | 10,563,748 | $76,798,448 | 2.81% |
JOHNSON & JOHNSON | 1,000,000 | $7,270,000 | 2.36% |
SPHERA FUNDS MANAGEMENT LTD. | 952,642 | $6,925,707 | 1.16% |
PFM Health Sciences, LP | 3,204,790 | $23,298,823 | 1.03% |
Pier Capital, LLC | 862,736 | $6,272,091 | 0.95% |
Boxer Capital, LLC | 2,500,000 | $18,175 | 0.89% |
Deep Track Capital, LP | 2,345,073 | $17,048,681 | 0.70% |
SILVERARC CAPITAL MANAGEMENT, LLC | 198,477 | $1,442,928 | 0.60% |